Sarepta Therapeutics
SRPT
#1634
Rank
โ‚น904.56 B
Marketcap
โ‚น9,335
Share price
3.58%
Change (1 day)
-12.43%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

EPS for Sarepta Therapeutics (SRPT)

EPS in 2023 (TTM): -โ‚น644.14

According to Sarepta Therapeutics 's latest financial reports the company's current EPS (TTM) is -โ‚น684.71. In 2022 the company made an earnings per share (EPS) of -โ‚น702.20 a decrease over its 2021 EPS that were of -โ‚น450.35.

EPS history for Sarepta Therapeutics from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น644.14-8.27%
2022-โ‚น702.2055.92%
2021-โ‚น450.35-27.16%
2020-โ‚น618.25-26.96%
2019-โ‚น846.4978.6%
2018-โ‚น473.96603.9%
2017-โ‚น67.33-85.9%
2016-โ‚น477.465.2%
2015-โ‚น453.8553.1%
2014-โ‚น296.45-0%
2013-โ‚น296.45-33.79%
2012-โ‚น447.737214.29%
2011-โ‚น6.12-96.11%
2010-โ‚น157.4015.38%
2009-โ‚น136.42-23.53%
2008-โ‚น178.39-37.04%
2007-โ‚น283.33-0%
2006-โ‚น283.3345.95%
2005-โ‚น194.13-46.38%
2004-โ‚น362.0340.82%
2003-โ‚น257.09-57.02%
2002-โ‚น598.14-2.56%
2001-โ‚น613.88138.78%
2000-โ‚น257.09-20.97%
1999-โ‚น325.30-72.2%
1998-โ‚น1,170519.44%
1997-โ‚น188.89

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
โ‚น383.89-156.07%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น628.74-8.17%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น271.09-60.41%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น109.31-84.04%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น359.41-47.51%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น756.42 10.47%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น460.85-32.69%๐Ÿ‡บ๐Ÿ‡ธ USA